Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 27, 2020AJP Gastrointestinal and Liver PhysiologyOpen Access

Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

JCJohn Y.L. ChiangNortheast Ohio Medical UniversityJFJessica M. FerrellNortheast Ohio Medical University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chiang et al. (2020) studied this question.

synapsesocial.com/papers/69d8be4502f13db44fbed85bhttps://doi.org/10.1152/ajpgi.00223.2019
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Bile acid metabolism and signaling in liver disease and therapy2017 · 308 citations
  2. 2Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism2017 · 255 citations
  3. 3Intestine farnesoid X receptor agonist and the gut microbiota activate G‐protein bile acid receptor‐1 signaling to improve metabolism2018 · 569 citations
  4. 4Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice2012 · 153 citations
  5. 5Microbiota-induced obesity requires farnesoid X receptor2016 · 475 citations